Decellularized ECM |
Containing proteins, glycoproteins, and polysaccharides |
Binding to the specific surface receptors of immune cells, the ECM composition can affect immunomodulation, promoting anti-inflammatory phenotype polarization in some cases |
[230,243,244,245] |
Collagen |
Protein-based material and the most abundant ECM component |
Binding to LAIR-1 receptors on immune cells, suppressing immune cell activity, and resolving post-wound inflammation |
[246,247] |
Fibrin |
The main component of the haemostatic clot |
Decreasing TNF-α cytokine secretion, decreasing macrophage motility, reduction of neutrophil recruitment, and extending pro-healing effects |
[248,249,250,251,252] |
Hyaluronic acid |
Glycosaminoglycans material with various MWs |
Modulation of leukocyte function, immunomodulatory effect dependent on MW, suppressing immune cell activity by high-MW HA, enhancing an inflammatory by low-MW HA, delaying inflammation by High-MW HA |
[253,254] |
Chitosan |
A natural polysaccharide |
Employing leukocytes and macrophages to the wound site, decreasing the inflammatory cells, and TNF-α and MMP-9 levels, and affecting macrophage polarization |
[255,256,257,258] |
Carrageenan |
A natural marine polysaccharide from red seaweed |
Stimulating IL-10 expression, prohibiting cytotoxic T cell responses, and delaying neutrophil activation |
[259,260,261] |
L-arginine |
Amino acid-based material |
Decreasing nitric oxide production, stimulating macrophages to express both TNF-α and NO in combination with chitosan |
[262,263,264] |